دورية أكاديمية
أعرض في EDS

Characteristics associated with anti-HCV serological markers in prisoners in the state of Paraná, Brazil: a case-control study.

التفاصيل البيبلوغرافية
العنوان: Characteristics associated with anti-HCV serological markers in prisoners in the state of Paraná, Brazil: a case-control study.
المؤلفون: Silva TMPM; Western Paraná State University, Department of Life Sciences, Postgraduate Program in Applied Health Sciences, Francisco Beltrão, PR, Brazil., Ferreto LED; Western Paraná State University, Department of Life Sciences, Postgraduate Program in Applied Health Sciences, Francisco Beltrão, PR, Brazil. Electronic address: liraneferreto@uol.com.br., Follador FAC; Western Paraná State University, Department of Life Sciences, Postgraduate Program in Applied Health Sciences, Francisco Beltrão, PR, Brazil., Vieira AP; Western Paraná State University, Department of Life Sciences, Postgraduate Program in Applied Health Sciences, Francisco Beltrão, PR, Brazil., Yamada RS; Western Paraná State University, Department of Life Sciences, General Surgery Residency Program, Francisco Beltrão, PR, Brazil., Lucio LC; Western Paraná State University, Department of Life Sciences, Postgraduate Program in Applied Health Sciences, Francisco Beltrão, PR, Brazil., Titon JP; Western Paraná State University, Department of Life Sciences, General Surgery Residency Program, Francisco Beltrão, PR, Brazil., Torres RH; Division of Public Security and Penitentiary Administration, Penitentiary Deparment, Curitiba, PR, Brazil., Amaral GCD; 15th Health Division, State Health Office, Maringá, PR, Brazil., Coelho HC; São Paulo State University, Department of Pharmacy, Ribeirão Preto, SP, Brazil.
المصدر: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases [Braz J Infect Dis] 2019 May - Jun; Vol. 23 (3), pp. 173-181. Date of Electronic Publication: 2019 Jun 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Editora Country of Publication: Brazil NLM ID: 9812937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1678-4391 (Electronic) Linking ISSN: 14138670 NLM ISO Abbreviation: Braz J Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: 2010- : Rio de Janeiro : Elsevier Editora
Original Publication: Salvador, Bahia, Brazil : Contexto, c1997-
مواضيع طبية MeSH: Hepacivirus/*immunology , Hepatitis C/*epidemiology , Hepatitis C Antibodies/*blood , Prisoners/*statistics & numerical data, Adult ; Brazil/epidemiology ; Epidemiologic Methods ; Humans ; Male ; Middle Aged ; Seroepidemiologic Studies ; Socioeconomic Factors
مستخلص: Background: The prison system in Paraná, Brazil, is experiencing serious problems related to the increasing number of prisoners. Control of hepatitis C virus (HCV) has become more intense because the incarcerated population is considered a high-risk group for contagious diseases due to the favorable conditions found in prisons for the spread of these morbidities. The objective of this study was to identify features associated with hepatitis C infection among male prisoners in correctional institutions of Paraná state, Brazil.
Methods: This was a case-control study (27 cases and 54 controls) of men incarcerated in 11 penitentiaries in Paraná, Brazil. Information was obtained through a questionnaire in a cross-sectional epidemiological survey on HCV infection during the period from May 2015 to December 2016. Eligible men were recruited after testing positive for anti-HCV antibodies. Cases and controls were selected based on serological results of enzyme-linked immunosorbent assays and were matched by age, location of the penitentiary, and time in prison. Logistic regression analysis was used to identify risk factors for HCV seropositivity.
Results: The main significant independent risk factor for the acquisition of HCV infection was the use of injectable drugs (OR = 4.00; 95%CI:1.41-11.35; p < 0.001).
Conclusions: This study provides evidence that HCV infection is associated with drug use by this population. This information is pivotal for tailoring prevention programs and guiding specific socioeducational measures that aim to reduce or prevent HCV transmission within the prison setting.
(Copyright © 2019 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. All rights reserved.)
References: J Infect Public Health. 2013 Jun;6(3):186-95. (PMID: 23668463)
Rev Soc Bras Med Trop. 2000 Jan-Feb;33(1):27-30. (PMID: 10881115)
J Infect Dis. 2011 Dec 15;204(12):1830-8. (PMID: 22013220)
Cien Saude Colet. 2012 May;17(5):1235-46. (PMID: 22634816)
Int J Drug Policy. 2015 Oct;26(10):899-910. (PMID: 26254495)
BMC Public Health. 2014 Aug 11;14:830. (PMID: 25113132)
Am J Gastroenterol. 2009 Apr;104(4):1024-31. (PMID: 19240708)
AIDS Care. 2014;26(9):1122-6. (PMID: 24499303)
Rev Assoc Med Bras (1992). 2011 Jan-Feb;57(1):107-12. (PMID: 21390467)
J Infect Public Health. 2014 Nov-Dec;7(6):517-21. (PMID: 25182508)
Harm Reduct J. 2018 May 9;15(1):24. (PMID: 29739400)
World J Hepatol. 2015 Sep 28;7(21):2323-30. (PMID: 26413221)
BMC Infect Dis. 2013 Feb 01;13:60. (PMID: 23374914)
Cien Saude Colet. 2016 Jun;21(7):2031-40. (PMID: 27383337)
Hum Vaccin Immunother. 2015;11(11):2615-26. (PMID: 26158401)
Rev Soc Bras Med Trop. 2009 Jul-Aug;42(4):369-72. (PMID: 19802469)
World J Gastroenterol. 2011 Jul 7;17(25):3027-34. (PMID: 21799649)
Lancet. 2016 Sep 10;388(10049):1089-1102. (PMID: 27427453)
Lancet Infect Dis. 2018 Dec;18(12):1397-1409. (PMID: 30385157)
Drug Alcohol Depend. 2015 Jun 1;151:68-75. (PMID: 25861943)
Clin Infect Dis. 2013 Aug;57 Suppl 2:S32-8. (PMID: 23884063)
Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):413-27. (PMID: 23199501)
PLoS One. 2017 Jan 6;12(1):e0169195. (PMID: 28060860)
Clin Infect Dis. 2003 Aug 15;37(4):514-20. (PMID: 12905135)
Int J Prev Med. 2012 Mar;3(Suppl 1):S156-61. (PMID: 22826759)
PLoS One. 2017 Jun 27;12(6):e0179931. (PMID: 28654650)
Am J Public Health. 2014 Sep;104(9):1722-7. (PMID: 25033142)
J Public Health (Oxf). 2011 Jun;33(2):197-204. (PMID: 21345883)
BMC Public Health. 2010 Oct 22;10:633. (PMID: 20964864)
Eur J Epidemiol. 2010 Feb;25(2):143-8. (PMID: 20084429)
Med J Aust. 2014 Mar 17;200(5):277-80. (PMID: 24641153)
BMJ Open. 2014 Oct 19;4(10):e005694. (PMID: 25331969)
J Viral Hepat. 2018 Nov;25(11):1260-1269. (PMID: 29851232)
J Infect Dis. 2010 Oct 1;202(7):984-90. (PMID: 20726768)
J Infect Dev Ctries. 2013 Jun 15;7(6):453-67. (PMID: 23771289)
Rev Bras Epidemiol. 2012 Sep;15(3):627-38. (PMID: 23090309)
J Epidemiol Community Health. 2008 Apr;62(4):305-13. (PMID: 18339822)
J Med Microbiol. 2007 Mar;56(Pt 3):391-397. (PMID: 17314372)
Epidemiol Rev. 2018 Jun 1;40(1):58-69. (PMID: 29860343)
BMC Public Health. 2013 Oct 20;13:981. (PMID: 24139133)
Rev Saude Publica. 2015;49:36. (PMID: 26247383)
J Urban Health. 2015 Apr;92(2):387-99. (PMID: 25450518)
World J Gastroenterol. 2015 Oct 14;21(38):10790-810. (PMID: 26478671)
Trop Med Int Health. 2018 Jun;23(6):641-649. (PMID: 29698576)
فهرسة مساهمة: Keywords: Hepatitis C; Prisoners; Risk factors
المشرفين على المادة: 0 (Hepatitis C Antibodies)
تواريخ الأحداث: Date Created: 20190623 Date Completed: 20190903 Latest Revision: 20220902
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9428240
DOI: 10.1016/j.bjid.2019.05.007
PMID: 31228459
قاعدة البيانات: MEDLINE
الوصف
تدمد:1678-4391
DOI:10.1016/j.bjid.2019.05.007